Workflow
Pharma and Healthcare
icon
Search documents
ARS Pharmaceuticals: What We Learned From Q3 Earnings - Why I Maintain Hold Rating
Seeking Alphaยท 2025-11-10 18:59
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?When I last covered ARS Pharmaceuticals, Inc. ( SPRY ) - the marketer and seller of Neffy, for the needle-free intranasal delivery of epinephrine for the emergency treatment of Type I allergic reactions, including ...